JESUS GONZALEZ: Open Payments
NPI 1538424445 · MCALLEN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$394 in 17 payments from 8 companies in 2025. Trend: 2023 $155 · 2024 $576 · 2025 $394
Food & beverage: $394
| Company | Payments | Amount |
|---|---|---|
| AKEBIA THERAPEUTICS INC | 1 | $83 |
| Otsuka America Pharmaceutical, Inc. | 3 | $52 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $52 |
| Calliditas Therapeutics US Inc. | 2 | $52 |
| Fresenius USA Marketing, Inc. | 2 | $50 |
| AstraZeneca Pharmaceuticals LP | 3 | $49 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $40 |
| Amgen Inc. | 1 | $16 |
Products named: Vafseo, JARDIANCE, TARPEYO, VELPHORO, Kerendia, JYNARQUE, FARXIGA, LOKELMA.
Industry payments across TX — which companies pay providers there.
